Chitosan and chitosan/β‐cyclodextrin microspheres as sustained‐release drug carriers
Authors:
- 29 October 2006
- journal article
- research article
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 103 (2) , 1183-1190
Abstract
The main aim of this study was to compare two microspheres, chitosan (CTS) and CTS/β‐cyclodextrin (β‐CD), made by spray‐drying, as pulmonary sustained drug‐delivery carriers. Theophylline (TH) was used as a model drug. The characteristics of the microspheres and in vitro release were studied. The yield of CTS/β‐CD microspheres was 46.1%, which was higher than that of the CTS microspheres (36.5%). The drug loads of the CTS and CTS/β‐CD microspheres were 22.7 and 21.1%, respectively, whereas the encapsulation efficiencies were 90.7 and 91.4%, respectively. The distribution of 50% [(diameter) d (0.5)] of the CTS microspheres was below 6.49 μm and that of the CTS/β‐CD microspheres was below 4.90 μm. Scanning electron microscopy showed that both microspheres yielded a spherical shape with smooth or wrinkled surfaces. Fourier transform infrared spectroscopy demonstrated that the carbonyl group of TH formed hydrogen bonds with the amide group of CTS and the hydroxyl group of β‐CD. The swelling ability of the two microspheres was more than three times their weight, and their humidity rates attained equilibrium within 24 h. The ciliary beat movement times of CTS and CTS/β‐CD microspheres were 493.00 and 512.33 min, respectively, which indicated that the two microspheres effectively reduced the ciliotoxicity and possessed better adaptability. In vitro release of TH from CTS/β‐CD microspheres was slower than that from CTS microspheres at pH 6.8 and provided a sustained release of 72.0% within 12 h. The results suggest that CTS/β‐CD microspheres are a promising carrier for sustained release for pulmonary delivery. © 2006 Wiley Periodicals, Inc. J Appl Polym Sci 103: 1183–1190, 2007Keywords
This publication has 27 references indexed in Scilit:
- Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctionsJournal of Controlled Release, 2005
- Effect of chitosan on progesterone release from hydroxypropyl-β-cyclodextrin complexesInternational Journal of Pharmaceutics, 2003
- Pulmonary Gene Delivery by Chitosan–pDNA Complex Powder Prepared by a Supercritical Carbon Dioxide ProcessJournal of Pharmaceutical Sciences, 2003
- Formulation factors in preparing BTM–chitosan microspheres by spray drying methodInternational Journal of Pharmaceutics, 2002
- Delivery of peptide and non-peptide drugs through the respiratory tractPharmaceutical Science & Technology Today, 1999
- Chitosan microspheres prepared by spray dryingInternational Journal of Pharmaceutics, 1999
- Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramideEuropean Journal of Pharmaceutics and Biopharmaceutics, 1999
- Investigation of a pMDI system containing chitosan microspheres and P134aInternational Journal of Pharmaceutics, 1998
- Chitosan sponges as sustained release drug carriersInternational Journal of Pharmaceutics, 1997
- Preparation and Characterization of Freeze-dried Chitosan-Poly(Ethylene Oxide) Hydrogels for Site-Specific Antibiotic Delivery in the StomachPharmaceutical Research, 1996